773134-18-2

Basic information

• Product Name: 5-Chloro-2-hydroxy-4-Methyl-benzoic acid Methyl ester
• Synonyms: 5-Chloro-2-hydroxy-4-Methyl-benzoic acid Methyl ester;methyl 5-chloro-2-hydroxy-4-methylbenzoate
• CAS NO: 773134-18-2
• Molecular Formula: C9H9ClO3
• Molecular Weight: 200.61896
• Mol File: 773134-18-2.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-Chloro-2-hydroxy-4-Methyl-benzoic acid Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Chloro-2-hydroxy-4-Methyl-benzoic acid Methyl ester(773134-18-2)
• EPA Substance Registry System: 5-Chloro-2-hydroxy-4-Methyl-benzoic acid Methyl ester(773134-18-2)

Safety Data

• Hazardous Substances Data: 773134-18-2(Hazardous Substances Data)

Upstream product

• 4670-56-8 methyl 2-hydroxy-4-methylbenzoate 
• 50-85-1 2-hydroxy-p-toluic acid 
• 67-56-1 methanol 
• 35458-35-6 5-chloro-2-hydroxy-4-methyl-benzoic acid 

Relevant articles and documents

SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME

The present invention includes substituted 1,1'-biphenyl compounds, analogues thereof, and compositions comprising the same. In one aspect, the compounds contemplated in the invention can be used to treat, ameliorate, or prevent hepatitis B virus (HBV) and/or hepatitis D virus (HDV) infections in a patient. In another aspect, the compounds contemplated in the invention can be used to treat, ameliorate, and/or prevent cancer in a patient.

2 - (BENZYLOXY) BENZAMIDES AS LRRK2 KINASE INHIBITORS

The present invention relates to novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by LRRK2 kinase activity, for example Parkinson's disease or Alzheimer's disease.